title: C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.
abstract: The expression of the receptor for the anaphylatoxin C5a on mast cells was studied with three monoclonal antibodies directed to the N-terminal domain of the C5a receptor. Human skin was investigated by immunohistology applied to sequential 2 micron sections of acrylate-embedded tissues. All anti-C5a receptor antibodies stained c-kit+ or tryptase+ cells which were metachromatic after toluidine blue staining in normal human skin. The binding of anti-C5a receptor antibodies was inhibitable by a peptide representing the first 31 amino acids of the C5a receptor. A similar expression of C5a receptors was found on mast cells in chronic psoriatic plaques. However, C5a receptors were not detectable on mast cells in weal and flare reactions or in lesional skin of uticaria pigmentosa. These findings suggest that (1) anti-C5a receptor antibodies directed to the N-terminal domain of the receptor are suitable tools for the identification of mast cells in acrylate-embedded sections of human skin, (2) mast cell activation in weal and flare reactions results in C5a receptor downregulation or receptor blockade and (3) mast cells in urticaria pigmentosa lack a typical marker of normal human skin mast cells.
authors.affiliation: Dermatologische Klinik und Poliklinik, Medizinischen Hochschule Hannover, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Werfel
authors.forename: M
authors.initials: M
authors.lastname: Oppermann
authors.forename: G
authors.initials: G
authors.lastname: Begemann
authors.forename: O
authors.initials: O
authors.lastname: Götze
authors.forename: J
authors.initials: J
authors.lastname: Zwirner
mesh_terms: D000911:Antibodies, Monoclonal; D000937:Antigen-Antibody Reactions; D015703:Antigens, CD / Q000032:analysis*; D016022:Case-Control Studies; D015936:Complement C5a; D004342:Drug Hypersensitivity; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced; D007150:Immunohistochemistry; D008407:Mast Cells / Q000737:chemistry*; D011565:Psoriasis / Q000378:metabolism* / Q000473:pathology; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000032:analysis*; D012016:Reference Values; D012867:Skin / Q000378:metabolism*; D016610:Tissue Embedding; D014582:Urticaria Pigmentosa / Q000378:metabolism* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D015936:Complement C5a